Frailty and Biological Age
- PMID: 34399574
- PMCID: PMC8497950
- DOI: 10.4235/agmr.21.0080
Frailty and Biological Age
Abstract
A reliable model of biological age is instrumental in the field of geriatrics and gerontology. This model should account for the heterogeneity and plasticity of aging and also accurately predict aging-related adverse outcomes. Epigenetic age models are based on DNA methylation levels at selected genomic sites and can be significant predictors of mortality and healthy/unhealthy aging. However, the biological function of DNA methylation at selected sites is yet to be determined. Frailty is a syndrome resulting from decreased physiological reserves and resilience. The frailty index is a probability-based extension of the concept of frailty. Defined as the proportion of health deficits, the frailty index quantifies the progression of unhealthy aging. The frailty index is currently the best predictor of mortality. It is associated with various biological factors and provides insight into the biological processes of aging. Investigation of the multi-omics factors associated with the frailty index will provide further insight.
Keywords: Aging; DNA Methylation; Frailty; Gene expression; Healthy aging.
Conflict of interest statement
The researchers claim no conflicts of interest.
Figures
References
-
- Finch C. Longevity, senescence, and the genome. Chicago, IL: University of Chicago Press; 1990.
-
- Benjamin H. Biologic versus chronologic age. J Gerontol. 1947;2:217–27. - PubMed
-
- Mitchell SJ, Scheibye-Knudsen M, Longo DL, de Cabo R. Animal models of aging research: implications for human aging and age-related diseases. Annu Rev Anim Biosci. 2015;3:283–303. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
